Headline of the Day

A new study has found that the antimalarial drug hydroxychloroquine helped patients survive COVID-19 while in the hospital, countering the establishment media’s criticism of President Donald Trump when he suggested the same thing.

The study was conducted by a team at Henry Ford Health System in Southeast Michigan and published in the International Journal of Infectious Diseases on Thursday.

Researchers studied a group of 2,541 hospitalized patients and found mortality rates were substantially reduced when patients were treated with hydroxychloroquine.

The study found that 13 percent of patients treated with just hydroxychloroquine died compared with 26.4 percent not treated with the drug.

“Overall crude mortality rates were 18.1 percent in the entire cohort, 13.5 percent in the hydroxychloroquine alone group, 20.1 percent among those receiving hydroxychloroquine + azithromycin, 22.4 percent among the azithromycin alone group, and 26.4 percent for neither drug,” the study’s report read.

TRENDING: Fox News Fires Veteran Anchor After Sexual Misconduct Allegation

Dr. Marcus Zervos, the division head of infectious disease for Henry Ford Health System, said in a news release that the study’s findings have been analyzed and peer-reviewed.

“We attribute our findings that differ from other studies to early treatment, and part of a combination of interventions that were done in supportive care of patients, including careful cardiac monitoring,” Zervos said.

“Our dosing also differed from other studies not showing a benefit of the drug. And other studies are either not peer reviewed, have limited numbers of patients, different patient populations or other differences from our patients.”

He added in a news conference that the drug had the most benefit when patients were treated early, CNN reported.

Completing this poll entitles you to The Western Journal news updates free of charge. You may opt out at anytime. You also agree to our Privacy Policy and Terms of Use.

The use of the drug has been criticized and questioned for months.

A May 22 study posted in The Lancet used data from Surgisphere to conclude that coronavirus patients taking chloroquine or hydroxychloroquine were more likely to die in the hospital, Science reported.

Within days of study’s publication, randomized trials of hydroxychloroquine came to a stop, including part of the World Health Organization’s trial of potential COVID-19 treatments. However, the data used in that study has since been scrutinized and described as “flawed.”

When Trump began taking hydroxychloroquine as a way to prevent him from contracting COVID-19, the mainstream media and Democrats mocked him for it.

House Speaker Nancy Pelosi responded to the news by describing him as “morbidly obese,” while Senate Minority Leader Chuck Schumer told MSNBC the president’s announcement was “reckless.”